Functional integration of microRNAs into oncogenic and tumor suppressor pathways

Craig D. Lotterman, Oliver A. Kent, Joshua T. Mendell

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

A large body of evidence has documented abnormal microRNA (miRNA) expression patterns in diverse human malignancies. Given that miRNA expression is tightly regulated during development and cellular differentiation, aberrant miRNA expression in cancer cells is likely to be in part a consequence of the loss of normal cellular identity that accompanies malignant transformation. Nevertheless, it is now clear that miRNAs function as critical effectors of several canonical oncogenic and tumor suppressor pathways, including those controlled by Myc and p53. Gain- and loss-of-function of these factors in cancer cells contributes to miRNA dysregulation, directly influencing neoplastic phenotypes including cellular proliferation and apoptosis.

Original languageEnglish (US)
Pages (from-to)2493-2499
Number of pages7
JournalCell Cycle
Volume7
Issue number16
StatePublished - Aug 15 2008

Fingerprint

MicroRNAs
Tumors
Neoplasms
Cells
Cell Proliferation
Apoptosis
Phenotype

Keywords

  • c-Myc
  • Fusion oncoprotein
  • Gene expression
  • microRNA
  • Nuclear factorκB
  • Oncogene
  • p53
  • Tumor suppressor

ASJC Scopus subject areas

  • Cell Biology
  • Biochemistry
  • Molecular Biology

Cite this

Functional integration of microRNAs into oncogenic and tumor suppressor pathways. / Lotterman, Craig D.; Kent, Oliver A.; Mendell, Joshua T.

In: Cell Cycle, Vol. 7, No. 16, 15.08.2008, p. 2493-2499.

Research output: Contribution to journalArticle

Lotterman, Craig D. ; Kent, Oliver A. ; Mendell, Joshua T. / Functional integration of microRNAs into oncogenic and tumor suppressor pathways. In: Cell Cycle. 2008 ; Vol. 7, No. 16. pp. 2493-2499.
@article{e42a40419c7d4052a7455c713fe38b10,
title = "Functional integration of microRNAs into oncogenic and tumor suppressor pathways",
abstract = "A large body of evidence has documented abnormal microRNA (miRNA) expression patterns in diverse human malignancies. Given that miRNA expression is tightly regulated during development and cellular differentiation, aberrant miRNA expression in cancer cells is likely to be in part a consequence of the loss of normal cellular identity that accompanies malignant transformation. Nevertheless, it is now clear that miRNAs function as critical effectors of several canonical oncogenic and tumor suppressor pathways, including those controlled by Myc and p53. Gain- and loss-of-function of these factors in cancer cells contributes to miRNA dysregulation, directly influencing neoplastic phenotypes including cellular proliferation and apoptosis.",
keywords = "c-Myc, Fusion oncoprotein, Gene expression, microRNA, Nuclear factorκB, Oncogene, p53, Tumor suppressor",
author = "Lotterman, {Craig D.} and Kent, {Oliver A.} and Mendell, {Joshua T.}",
year = "2008",
month = "8",
day = "15",
language = "English (US)",
volume = "7",
pages = "2493--2499",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "16",

}

TY - JOUR

T1 - Functional integration of microRNAs into oncogenic and tumor suppressor pathways

AU - Lotterman, Craig D.

AU - Kent, Oliver A.

AU - Mendell, Joshua T.

PY - 2008/8/15

Y1 - 2008/8/15

N2 - A large body of evidence has documented abnormal microRNA (miRNA) expression patterns in diverse human malignancies. Given that miRNA expression is tightly regulated during development and cellular differentiation, aberrant miRNA expression in cancer cells is likely to be in part a consequence of the loss of normal cellular identity that accompanies malignant transformation. Nevertheless, it is now clear that miRNAs function as critical effectors of several canonical oncogenic and tumor suppressor pathways, including those controlled by Myc and p53. Gain- and loss-of-function of these factors in cancer cells contributes to miRNA dysregulation, directly influencing neoplastic phenotypes including cellular proliferation and apoptosis.

AB - A large body of evidence has documented abnormal microRNA (miRNA) expression patterns in diverse human malignancies. Given that miRNA expression is tightly regulated during development and cellular differentiation, aberrant miRNA expression in cancer cells is likely to be in part a consequence of the loss of normal cellular identity that accompanies malignant transformation. Nevertheless, it is now clear that miRNAs function as critical effectors of several canonical oncogenic and tumor suppressor pathways, including those controlled by Myc and p53. Gain- and loss-of-function of these factors in cancer cells contributes to miRNA dysregulation, directly influencing neoplastic phenotypes including cellular proliferation and apoptosis.

KW - c-Myc

KW - Fusion oncoprotein

KW - Gene expression

KW - microRNA

KW - Nuclear factorκB

KW - Oncogene

KW - p53

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=49749084410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49749084410&partnerID=8YFLogxK

M3 - Article

C2 - 18719378

AN - SCOPUS:49749084410

VL - 7

SP - 2493

EP - 2499

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 16

ER -